AKAN - Financial Reports List - Akanda Corp. - IntrinsicAlpha

Akanda Corp. AKAN

Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - GB

$ 1.2249

1.63 %

$ 2.79 M

Market Cap

-0.4

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Annual Report	FY	10-K	2024-12-31	-61.27%	87.31%	56.40%
Quarterly Report	Q2	8-K	2024-06-30	552.57%	-3.44%	78.52%
Quarterly Report	Q4	8-K	2023-12-31	3068.03%	-838.97%	-60.29%
Annual Report	FY	10-K	2023-12-31	-17.55%	-8128.82%	50.18%
Quarterly Report	Q2	8-K	2023-06-30	35422.19%	-3914.51%	-3975.15%
Quarterly Report	Q4	8-K	2022-12-31	929310.95%	-1548.28%	-1646.07%
Annual Report	FY	10-K	2022-12-31	6223.00%	104.30%	-195.25%
Quarterly Report	Q2	8-K	2022-06-30	0.00%	-174.70%	-2330.26%
Quarterly Report	Q4	8-K	2021-12-31	0.00%	-197.74%	-485.68%
Annual Report	FY	10-K	2021-12-31	1909.26%	-213.11%	-310.23%

1